We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current VBS market cap is 4.1M. The company's latest EPS is AUD -0.0439 and P/E is -1.82.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 50k | 1.02M | 1.3M | 1.3M | 1.06M |
Operating Income | -2.67M | -2.79M | -3.3M | -3.29M | -2.41M |
Net Income | -3M | -3.86M | -3.99M | -3.44M | -2.34M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 3M | 6.98M | 3.94M | 4.63M | 2.03M |
Total Liabilities | 8.64M | 8.87M | 7.47M | 863k | 540k |
Total Equity | -5.65M | -1.89M | -3.53M | 3.77M | 1.49M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -3M | -3.26M | -4.44M | -2.35M | -2.03M |
Investing | N/A | N/A | -21k | -17k | -68k |
Financing | 5.64M | 6.35M | -35k | 4.04M | -41k |
Market Cap | 4.1M |
Price to Earnings Ratio | -1.82 |
Price to Sales Ratio | 4 |
Price to Cash Ratio | 5.26 |
Price to Book Ratio | 2.86 |
Dividend Yield | - |
Shares Outstanding | 53.21M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -75.56% |
52 Week High | 0.32 |
52 Week Low | 0.076 |
Spread (Intraday) | 0 (1.27%) |
Company Name | Vectus Biosystems Limited |
Address |
unit 5 sydney, new south wales 2018 |
Website | https://www.vectusbiosystems.com.au |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions